Suppr超能文献

情感障碍中的红细胞膜钠钾三磷酸腺苷酶活性

Erythrocyte membrane sodium-potassium adenosine triphosphatase activity in affective disorders.

作者信息

Reddy P L, Khanna S, Subhash M N, Channabasavanna S M, Rao B S

机构信息

Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bangalore, India.

出版信息

J Neural Transm Gen Sect. 1992;89(3):209-18. doi: 10.1007/BF01250673.

Abstract

Erythrocyte membrane Na+,K(+)-ATPase activity was studied in drug naive patients with bipolar (BP) mania (n = 62) and unipolar (UP) depression (n = 60) and normal controls (n = 66). Compared to controls there was a significantly decreased Na+,K(+)-ATPase activity in UP depressives but no change in BP manics. However, lithium treatment caused a significant increase in Na+,K(+)-ATPase activity although there was no correlation between plasma lithium levels and enzyme activity. Plasma cortisol correlated inversely with Na+,K(+)-ATPase in UP depressives. Interestingly, the lithium responders [less than 50% Beck Rafaelson's Mania Rating Scale (BRMS) score] showed a significant increase in Na+,K(+)-ATPase activity compared to lithium nonresponders (greater than 50% BRMS score). These observations indicate that monitoring of Na+,K(+)-ATPase activity during lithium therapy is useful to predict a therapeutic response.

摘要

在未服用过药物的双相(BP)躁狂症患者(n = 62)、单相(UP)抑郁症患者(n = 60)和正常对照组(n = 66)中研究了红细胞膜钠钾ATP酶活性。与对照组相比,单相抑郁症患者的钠钾ATP酶活性显著降低,而双相躁狂症患者则无变化。然而,锂治疗导致钠钾ATP酶活性显著增加,尽管血浆锂水平与酶活性之间没有相关性。在单相抑郁症患者中,血浆皮质醇与钠钾ATP酶呈负相关。有趣的是,与锂治疗无反应者(贝克-拉法尔森躁狂量表(BRMS)评分大于50%)相比,锂治疗有反应者(BRMS评分小于50%)的钠钾ATP酶活性显著增加。这些观察结果表明,在锂治疗期间监测钠钾ATP酶活性有助于预测治疗反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验